文档介绍：work®*,MD/・Barthel,&ResearchInstitute*TaniosBekaii-Saab,&,,MD,MPHfDana-Farber/BrighamandWomen'sCancerCenterHansGerdes,MDnbMemorialSloan・,MD,MBA§prehensiveCancerCenterLisaHazard,MD§,MD,PhDfMemorialSloan-,MD§prehensiveCancerCenteratJohnsHopkinsMaryFrancesMcAleer,MD,PhD§,,,prehensiveCancerCenter*,'sResearchHospital/,,,MDUFoxChaseCancerCenterStephenShibata,,MDFMemorialSloan-,,MD,PhDVanderbilt-lngramCancerCenterChristopherWillett,MD§prehensiveCancerCenterDouglasE・Wood,MDqFredHutchinsonCancerResearchCenter/,MDqMassachusettsGeneralHospital*GaryYang,MD§RoswellParkCancerInstituteTMedicaloncology口GastroenterologyUSurgery/SurgicaloncologyPInternalmedicine§Radiotherapy/RadiationoncologytHematology/HematologyoncologyPathology*mitteemember分期讨论参考临床试验:认为对任何肿瘤病人的最佳治疗是参与临床试验。参与临床试验是特别推荐的。食管癌指南成员指南更新内容汇总流程和评价(ESOPH-D体格健康,可切除的Tis,T1-T4,N0-1,NX或IVA期(ES0PH-2)手术结果(ESOPH-3)身体情况不适合手术,不可切除的T4,或不选择手术(ES0PII-4)随访,复发与姑息治疗(ESOPH-5)远处转移癌(ESOPH-6)联合治疗原则(ES0PH-A)外科原则(ESOPH-B)系统治疗原则(ESOPH-C)放疗原则(ESOPH-D)最佳支持原则(ESOPH-E)指南索引打印指南指南更新内容汇